TheraVac-01: Evaluation of Safety and Immunogenicity of the HIV-1 Vaccine NYVAC-B in Chronic HIV-1 Infected Patients Successfully Treated with HAART

被引:0
|
作者
Bart, P-A [1 ]
Harari, A. [1 ]
Vermeulen, J. N. [2 ,3 ]
Enders, F. Bellutti [1 ]
Bataenjer, E. Castro [1 ]
Cavassini, M. [1 ]
Wit, F. W. [2 ,3 ]
Autran, B. [4 ]
Lange, J. M. [2 ,3 ]
Pantaleo, G. [1 ]
机构
[1] CHU Vaudois, Lausanne, Switzerland
[2] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands
[3] IATEC, Amsterdam, Netherlands
[4] Fac Med Pierre & Marie Curie, Paris, France
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:149 / 149
页数:1
相关论文
共 50 条
  • [21] HIV-1 Meningoencephalitis in Patients on Effective HAART
    Lafeuillade, Alain
    Cheret, Antoine
    Hittinger, Gilles
    Poggi, Cecile
    HIV CLINICAL TRIALS, 2009, 10 (03): : 200 - 202
  • [22] Cognitive safety of interruption of HAART in HIV-1 infection
    Childers, ME
    Woods, SP
    Letendre, S
    Mindt, MR
    McCutchan, JA
    Ellis, RJ
    NEUROLOGY, 2004, 62 (07) : A408 - A408
  • [23] rAd5/NYVAC-B is superior to NYVAC-B/rAd5 and is dependent on rAd5 dose for neutralizing antibody responses against HIV-1
    DC Montefiori
    Y Huang
    S Karuna
    M Allen
    N Kochar
    S Chappuis
    J Gaillard
    G Tomaras
    B Graham
    P Bart
    G Pantaleo
    Retrovirology, 9
  • [24] Immunogenicity of 2 therapeutic mosaic HIV-1 vaccine strategies in individuals with HIV-1 on antiretroviral therapy
    Julg, Boris
    Stephenson, Kathryn E.
    Tomaka, Frank
    Walsh, Stephen R.
    Tan, C. Sabrina
    Lavreys, Ludo
    Sarnecki, Michal
    Ansel, Jessica L.
    Kanjilal, Diane G.
    Jaegle, Kate
    Speidel, Tessa
    Nkolola, Joseph P.
    Borducchi, Erica N.
    Braams, Esmee
    Pattacini, Laura
    Burgess, Eleanor
    Ilan, Shlomi
    Bartsch, Yannic
    Yanosick, Katherine E.
    Seaman, Michael S.
    Stieh, Daniel J.
    van Duijn, Janine
    Willems, Wouter
    Robb, Merlin L.
    Michael, Nelson L.
    Walker, Bruce D.
    Pau, Maria Grazia
    Schuitemaker, Hanneke
    Barouch, Dan H.
    NPJ VACCINES, 2024, 9 (01)
  • [25] Immunogenicity and safety of pandemic H1N1 2009 influenza vaccine for HIV-1 patients
    Jilich, D.
    Havlickova, M.
    Vesely, D.
    Rozsypal, H.
    Jirincova, H.
    Stankova, M.
    Kyncl, J.
    Maly, M.
    Machala, L.
    ACTA VIROLOGICA, 2012, 56 (04) : 349 - 351
  • [26] Evaluation of Cardiovascular Disease Risk in HIV-1–Infected Patients Treated with Darunavir
    Magda Opsomer
    Dessislava Dimitrova
    Johan Verspeelt
    Amy Purrington
    Abdul Mehbob
    Scott Chavers
    Helen Pai
    Simon Vanveggel
    Donghan Luo
    Kimberley Brown
    Christiane Moecklinghoff
    Richard E. Nettles
    Katia Boven
    Drugs in R&D, 2018, 18 : 199 - 210
  • [27] Assessment of the Safety and Immunogenicity of 2 Novel Vaccine Platforms for HIV-1 Prevention
    Baden, Lindsey R.
    Karita, Etienne
    Mutua, Gaudensia
    Bekker, Linda-Gail
    Gray, Glenda
    Page-Shipp, Liesl
    Walsh, Stephen R.
    Nyombayire, Julien
    Anzala, Omu
    Roux, Surita
    Laher, Fatima
    Innes, Craig
    Seaman, Michael S.
    Cohen, Yehuda Z.
    Peter, Lauren
    Frahm, Nicole
    McElrath, M. Juliana
    Hayes, Peter
    Swann, Edith
    Grunenberg, Nicole
    Grazia-Pau, Maria
    Weijtens, Mo
    Sadoff, Jerry
    Dally, Len
    Lombardo, Angela
    Gilmour, Jill
    Cox, Josephine
    Dolin, Raphael
    Fast, Patricia
    Barouch, Dan H.
    Laufer, Dagna S.
    ANNALS OF INTERNAL MEDICINE, 2016, 164 (05) : 313 - +
  • [28] Safety and immunogenicity of an adjuvanted protein therapeutic HIV-1 vaccine in subjects with HIV-1 infection: A randomised placebo-controlled study
    Harrer, Thomas
    Plettenberg, Andreas
    Arasteh, Keikawus
    Van Lunzen, Jan
    Faetkenheuer, Gerd
    Jaeger, Hans
    Janssens, Michel
    Burny, Wivine
    Collard, Alix
    Roman, Francois
    Loeliger, Alfred
    Koutsoukos, Marguerite
    Bourguignon, Patricia
    Lavreys, Ludo
    Voss, Gerald
    VACCINE, 2014, 32 (22) : 2657 - 2665
  • [29] Therapeutic immunization of highly active antiretroviral therapy-treated HIV-1-infected patients:: safety and immunogenicity of an HIV-1 gag/poly-epitope DNA vaccine
    Dorrell, L
    Yang, HB
    Iversen, AKN
    Conlon, C
    Suttill, A
    Lancaster, M
    Dong, T
    Cebere, I
    Edwards, A
    Rowland-Jones, S
    Hanke, T
    McMichael, AJ
    AIDS, 2005, 19 (12) : 1321 - 1323
  • [30] Hadache in HIV-1 Infected Patients
    De Marinis, M.
    Galasso, D.
    Colaizzo, E.
    Fimiani, C.
    CEPHALALGIA, 2013, 33 (S8) : 276 - 276